Results 131 to 140 of about 5,162 (179)

VCAM-1 as a biomarker of early cardiac phenotypic changes in Fabry disease. [PDF]

BMC Cardiovasc Disord
Lino DODC, Meneses GC, de Almeida IM, Martins AMC, Vasconcelos AJS, de Lima CJM, Rocha RPS, Daher EF, da Silva Junior GB.   +8 more
europepmc   +1 more source

Case Report: Is it COPD? It is Fabry disease: a case in which bronchodilators were briefly used but not continued, prioritizing enzyme replacement therapy. [PDF]

Front Pharmacol
Li Y, Zhu H, Zhan Z, Li G, Huang S, Xiao C, Li Y, Zheng C, Huang F.   +8 more
europepmc   +1 more source

Cardiomegaly of Unknown Origin: Why Morphology Still Matters in the Genetic Era - A Case of Cardiac Fabry Disease. [PDF]

Medeni Med J
Makarov I, Roy Y, Mitrofanova L.
europepmc   +1 more source

Genetic Modifiers of Cardiac Remodeling Severity in IVS4+919G>A-Associated Fabry Cardiomyopathy. [PDF]

Int J Mol Sci
Sung KT, Hsu CY, Lu YH, Hung CL, Niu DM.
europepmc   +1 more source

Latent Epstein-Barr Virus Infection Correlates with Glycosphingolipid Enrichment and Morphological Remodeling of Extracellular Particles. [PDF]

Biology (Basel)
Zollo A, Centofanti L, Citro V, Corona A, Mingione A, Monzani C, Giannandrea D, Colombo EA, Serrao G, Gervasini C, Massa V, Neri A, Priori A, Miozzo MR, Signorelli P, Chiaramonte R, Dei Cas M, Martinelli-Boneschi F.   +17 more
europepmc   +1 more source

Nucleoside-Modified mRNA Encoding Alpha-Galactosidase A Ameliorates Fabry Disease Phenotypes in Human IPSC-Derived Cardiomyocytes. [PDF]

Adv Sci (Weinh)
Juchem M, Oehlsen L, Ersoy S, Ye JL, Weber N, Mohr E, Agyapong W, Liu J, Fuchs M, Xiao K, Jahn C, Eggenschwiler R, Cantz T, Beimdiek J, Buettner FFR, Kraft T, Hegermann J, Knorr IJ, Ernst L, Feldbrügge L, Puffert R, Schmidt K, Bär C, Hoepfner J, Thum T.   +24 more
europepmc   +1 more source

Bridging Biochemical and Clinical Disease Burden in Fabry Disease: A Comparative Analysis of Lyso-Gb3, MSSI, DS3, and FASTEX. [PDF]

Int J Mol Sci
Ozturk S, Akyol EMB.
europepmc   +1 more source

Autophagy-Lysosomal Dysfunction as a Converging Mechanism of Cardiomyopathy in Lysosomal Storage Disorders: From Pathobiology to Targeted Therapy. [PDF]

Int J Mol Sci
Lee CL, Chuang CK, Chang YH, Chiu HC, Tu YR, Lo YT, Wu JY, Lin HY, Lin SP.   +8 more
europepmc   +1 more source

Beneficial bystander-enhanced cryptic splice rescue of cardiac-type Fabry GLA IVS4+919G>A by adenine base editing in patient fibroblasts. [PDF]

Gene Ther
Chao HC, Lu YY, Chiang YT, Chen YR, Yen CT, Huang CY, Chang SK, Cheng YF, Lu YH, Niu DM.   +9 more
europepmc   +1 more source

The Sphingolipid Balance and Endothelial Dysfunction in Lysosomal Storage Diseases: Shared Mechanisms in Gaucher, Niemann-Pick and Fabry Disease. [PDF]

Int J Mol Sci
Nekrasova A, Kutsev S, Shestopalov A.
europepmc   +1 more source